Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) ROCE % : 17.21% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gansu Longshenrongfa Pharmaceutical Industry Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Gansu Longshenrongfa Pharmaceutical Industry Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 17.21%.

Gansu Longshenrongfa Pharmaceutical Industry Co ROCE % Historical Data

The historical data trend for Gansu Longshenrongfa Pharmaceutical Industry Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gansu Longshenrongfa Pharmaceutical Industry Co ROCE % Chart

Gansu Longshenrongfa Pharmaceutical Industry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

2.83

0.78

-0.55

7.94

11.46

Gansu Longshenrongfa Pharmaceutical Industry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															16.92	9.83	10.54	11.37	17.21

Gansu Longshenrongfa Pharmaceutical Industry Co ROCE % Calculation

Gansu Longshenrongfa Pharmaceutical Industry Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	100.967	/	( ( (1317.51 - 407.32)	+	(1336.651 - 485.139) )	/ 2 )
	=	100.967	/	( (910.19	+	851.512)	/ 2 )
	=	100.967	/	880.851
	=	11.46 %

Gansu Longshenrongfa Pharmaceutical Industry Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	149.64	/	( ( (1336.651 - 485.139)	+	(1430.016 - 542.959) )	/ 2 )
	=	149.64	/	( ( 851.512	+	887.057 )	/ 2 )
	=	149.64	/	869.2845
	=	17.21 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Gansu Longshenrongfa Pharmaceutical Industry Co ROCE % Related Terms

Thank you for viewing the detailed overview of Gansu Longshenrongfa Pharmaceutical Industry Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (SZSE:300534) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 10, Defence Road, Dingyuan Town, Gansu Province, Lanzhou, CHN, 730101

Website

http://www.lsrfzy.com

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is mainly engaged in the pharmaceutical business. It is engaged in the research and development of new drugs, traditional Chinese medicine processing and production. Its products portfolio includes Yuan Hu Zhitong Dripping Pills, Qiwei Wenyang Capsule and Xiaoshuan Tongluo Tablets. Its products are used to adjust gas, promote blood circulation, relieve pain, relieve cough, eliminate phlegm, relieve asthma, clear heat, and dispel dampness, among others.

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Headlines

No Headlines